Activation of β2-adrenergic receptor by (R,R′)-4′-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells-Reference-Cited by-同舟云学术

Activation of β2-adrenergic receptor by (R,R′)-4′-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells

Published:2015-05 Issue:5 Volume:27 Page:997-1007
ISSN:0898-6568
Container-title:Cellular Signalling
language:en
Short-container-title:Cellular Signalling

Author:

Wnorowski Artur,Sadowska Mariola,Paul Rajib K.,Singh Nagendra S.,Boguszewska-Czubara Anna,Jimenez Lucita,Abdelmohsen Kotb,Toll Lawrence,Jozwiak Krzysztof,Bernier Michel,Wainer Irving W.

Funder

National Institute on Aging/NIH, NIA/NIH

Foundation for Polish Science

Publisher

Elsevier BV

Subject

Cell Biology

Reference60 articles.

1. Comparative molecular field analysis of fenoterol derivatives: A platform towards highly selective and effective β2-adrenergic receptor agonists

2. β2-Adrenergic Receptor Agonists Inhibit the Proliferation of 1321N1 Astrocytoma Cells

3. (R,R′)-4′-methoxy-1-naphthylfenoterol targets GPR55-mediated ligand internalization and impairs cancer cell motility

4. Expression Profiling of UVB Response in Melanocytes Identifies a Set of p53-Target Genes

5. Beta‐Adrenoceptor Activation Reduces Both Dermal Microvascular Endothelial Cell Migration via a cAMP‐Dependent Mechanism and Wound Angiogenesis

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Commonly Used Cosmetic Preservatives on Healthy Human Skin Cells;Cells;2023-04-03

2. A comprehensive pharmacological analysis of fenoterol and its derivatives to unravel the role of β2-adrenergic receptor in zebrafish;Biomedicine & Pharmacotherapy;2023-04

3. Psychostimulants Modafinil, Atomoxetine and Guanfacine Impair Bone Cell Differentiation and MSC Migration;International Journal of Molecular Sciences;2022-09-06

4. Increased expression of β2‐adrenoceptors is involved in vitiligo‐associated grey hair;Journal of the European Academy of Dermatology and Venereology;2022-07-11

5. Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β2 adrenergic agonist;Scientific Reports;2022-03-07